Skip to main content
. Author manuscript; available in PMC: 2021 Jul 9.
Published in final edited form as: J Med Chem. 2020 Jun 15;63(13):7186–7210. doi: 10.1021/acs.jmedchem.0c00456

Figure 3.

Figure 3.

Binding to BRD4-BD1 correlates with cellular antiproliferative potency: (A) BRD4-BD1 and BRD4-BD2 binding measured by TR-FRET for 1 compared to 27 (data normalized to DMSO as 100%); (B) BROMOscan of compound 27 against 40 bromodomain proteins; (C) correlation between BRD4-BD1 binding (TR-FRET) assay and potency for growth inhibition of MCF-7:CFR cells.